M. Jenusaitis Matthew's most recent trade in enVVeno Medical Corporation was a trade of 9,620 Common Stock done at an average price of $2.5 . Disclosure was reported to the exchange on Dec. 19, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
enVVeno Medical Corporation | Matthew Jenusaitis M. | Director | Purchase of securities on an exchange or from another person at price $ 2.53 per share. | 19 Dec 2024 | 9,620 | 16,545 (0%) | 0% | 2.5 | 24,339 | Common Stock |
enVVeno Medical Corporation | M. Jenusaitis Matthew | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Dec 2024 | 19,752 | 19,752 | - | - | Stock Options | |
enVVeno Medical Corporation | Matthew Jenusaitis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Dec 2023 | 13,856 | 13,856 | - | - | Stock Options | |
enVVeno Medical Corporation | Matthew Jenusaitis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2022 | 8,403 | 8,403 | - | - | Stock Options | |
enVVeno Medical Corporation | Matthew Jenusaitis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Sep 2022 | 1,041 | 6,925 (0%) | 0% | - | Common Stock | |
enVVeno Medical Corporation | Matthew Jenusaitis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Sep 2022 | 1,041 | 0 | - | - | Restricted Stock Units | |
enVVeno Medical Corporation | Matthew Jenusaitis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2021 | 7,211 | 7,211 | - | - | Stock Options | |
enVVeno Medical Corporation | Matthew Jenusaitis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Sep 2021 | 1,042 | 2,084 | - | - | Restricted Stock Units | |
enVVeno Medical Corporation | Matthew Jenusaitis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Sep 2021 | 1,042 | 5,884 (0%) | 0% | - | Common Stock | |
enVVeno Medical Corporation | Matthew Jenusaitis | Director | Purchase of securities on an exchange or from another person at price $ 7.70 per share. | 25 Aug 2021 | 1,300 | 4,842 (0%) | 0% | 7.7 | 10,010 | Common Stock, $$0.00001 par value |
enVVeno Medical Corporation | Matthew Jenusaitis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2021 | 5,673 | 5,673 | - | - | Stock Option |